Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis
Allergy · 2023-05 · 78 (5) · 1169-1203
DOI: 10.1111/all.15679 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Allergy, online erschienen am 10.04.2023. Verfasst von J Bousquet und 59 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berl…. Hauptthemen laut MEDLINE: Rhinitis, Asthma, Rhinitis, Allergic. Die Arbeit wurde bisher 124-mal zitiert (Crossref) und nennt 299 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medical Research Council.
Abstract (Originalsprache)
Asthma, rhinitis, and atopic dermatitis (AD) are interrelated clinical phenotypes that partly overlap in the human interactome. The concept of “one‐airway‐one‐disease,” coined over 20 years ago, is a simplistic approach of the links between upper‐ and lower‐airway allergic diseases. With new data, it is time to reassess the concept. This article reviews (i) the clinical observations that led to Allergic Rhinitis and its Impact on Asthma (ARIA), (ii) new insights into polysensitization and multimorbidity, (iii) advances in mHealth for novel phenotype definitions, (iv) confirmation in canonical epidemiologic studies, (v) genomic findings, (vi) treatment approaches, and (vii) novel concepts on the onset of rhinitis and multimorbidity. One recent concept, bringing together upper‐ and lower‐airway allergic diseases with skin, gut, and neuropsychiatric multimorbidities, is the “Epithelial Barrier Hypothesis.” This review determined that the “one‐airway‐one‐disease” concept does not always hold true and that several phenotypes of disease can be defined. These phenotypes include an extreme “allergic” (asthma) phenotype combining asthma, rhinitis, and conjunctivitis. Rhinitis alone and rhinitis and asthma multimorbidity represent two distinct diseases with the following differences: (i) genomic and transcriptomic background (Toll‐Like Receptors and IL‐17 for rhinitis alone as a local disease; IL‐33 and IL‐5 for allergic and non‐allergic multimorbidity as a systemic disease), (ii) allergen sensitization patterns (mono‐ or pauci‐sensitization versus polysensitization), (iii) severity of symptoms, and (iv) treatment response. In conclusion, rhinitis alone (local disease) and rhinitis with asthma multimorbidity (systemic disease) should be considered as two distinct diseases, possibly modulated by the microbiome, and may be a model for understanding the epidemics of chronic and autoimmune diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Allergology and Immunology, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Berlin, Germany.
- University Hospital Montpellier, Montpellier, France.
- Inserm, Equipe d'Epidémiologie Respiratoire Intégrative, CESP, Villejuif, France.
- Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
- Sach´s Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden.
ORCID-Profile: J Bousquet, E Melén, T Haahtela, G H Koppelman, A Togias, R Valenta, C A Akdis, W Czarlewski, M Rothenberg, A Valiulis, M Wickman, M Akdis, D Aguilar, A Bedbrook, C Bindslev-Jensen, S Bosnic-Anticevich, L P Boulet, C E Brightling, L Brussino, E Burte, M Bustamante, G W Canonica, L Cecchi, J C Celedon, C Chaves Loureiro, E Costa, A A Cruz, M Erhola, B Gemicioglu, W J Fokkens, J Garcia-Aymerich, S Guerra, J Heinrich, J C Ivancevich, T Keil, L Klimek, P Kuna, M Kupczyk, V Kvedariene, D E Larenas-Linnemann, N Lemonnier, K C Lodrup Carlsen, R Louis, M Makela, M Makris, M Maurer, I Momas, M Morais-Almeida, J Mullol, R N Naclerio, K Nadeau, R Nadif, M Niedoszytko, Y Okamoto, M Ollert, N G Papadopoulos, G Passalacqua, V Patella, R Pawankar, N Pham-Thi
Förderung
- Medical Research Council
Zitieren
APA
Bousquet, J., Melén, E., Haahtela, T., Koppelman, G. H., Togias, A., Valenta, R., Akdis, C. A., Czarlewski, W., Rothenberg, M., Valiulis, A., Wickman, M., Akdis, M., Aguilar, D., Bedbrook, A., Bindslev-Jensen, C., Bosnic-Anticevich, S., Boulet, L. P., Brightling, C. E., Brussino, L., …, & Pham-Thi, N. (2023). Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis. Allergy, 78(5), 1169-1203. https://doi.org/10.1111/all.15679
Vancouver
Bousquet J, Melén E, Haahtela T, Koppelman GH, Togias A, Valenta R, et al. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis. Allergy. 2023;78(5):1169-1203. doi:10.1111/all.15679
BibTeX
@article{Bousquet2023,
author = {Bousquet, J and Melén, E and Haahtela, T and Koppelman, G H and Togias, A and Valenta, R and Akdis, C A and Czarlewski, W and Rothenberg, M and Valiulis, A and Wickman, M and Akdis, M and Aguilar, D and Bedbrook, A and Bindslev-Jensen, C and Bosnic-Anticevich, S and Boulet, L P and Brightling, C E and Brussino, L and Burte, E and Bustamante, M and Canonica, G W and Cecchi, L and Celedon, J C and Chaves Loureiro, C and Costa, E and Cruz, A A and Erhola, M and Gemicioglu, B and Fokkens, W J and Garcia-Aymerich, J and Guerra, S and Heinrich, J and Ivancevich, J C and Keil, T and Klimek, L and Kuna, P and Kupczyk, M and Kvedariene, V and Larenas-Linnemann, D E and Lemonnier, N and Lodrup Carlsen, K C and Louis, R and Makela, M and Makris, M and Maurer, M and Momas, I and Morais-Almeida, M and Mullol, J and Naclerio, R N and Nadeau, K and Nadif, R and Niedoszytko, M and Okamoto, Y and Ollert, M and Papadopoulos, N G and Passalacqua, G and Patella, V and Pawankar, R and Pham-Thi, N},
title = {Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis},
journal = {Allergy},
year = {2023},
volume = {78},
number = {5},
pages = {1169--1203},
doi = {10.1111/all.15679}
}
EUVIMED